Key result
Menopausal hormone therapy has no effect on overnight HRV in peri- and postmenopausal women.
Why the study?
Disturbed sleep is common during the climacteric and associated with increased sympathetic activity, but its effect on autonomic nervous function in climacteric women required evaluation.
Does menopausal hormone therapy or experimental sleep disturbance alter overnight heart rate variability in peri- and postmenopausal women?
RCT (n=35)
Does menopausal hormone therapy or experimental sleep disturbance alter overnight heart rate variability in peri- and postmenopausal women?
Menopausal hormone therapy and experimental sleep disturbance do not significantly impact overnight heart rate variability in climacteric women.
Answers are grounded in this paper and cite their sources.
Sleep disturbance may shift overnight HRV in climacteric women; leaves open net cardiovascular effects and need for larger trials.
OBJECTIVES: Disturbed sleep, common during the climacteric, is associated with increased sympathetic activity, a cardiovascular risk factor. We evaluated sleep disturbance effect on autonomic nervous function in climacteric women. METHODS: Seventeen perimenopausal and 18 postmenopausal women underwent a sleep study protocol: an adaptation night, a reference night, and a sleep disturbance night, with a hand loosely tied to the bed to allow blood sampling. This procedure was repeated after six months of menopausal hormone therapy (MHT) or placebo. Sleep disturbance and MHT effects on overnight heart rate variability (HRV) were analyzed. RESULTS: At baseline, sleep disturbance increased vagal HRV in postmenopausal women, but no changes were seen in perimenopausal women. At six months, sleep disturbance increased total HRV power in the perimenopausal placebo group, and increased nonlinear vagal HRV in the postmenopausal placebo group, but no other changes were seen. MHT did not have any effects on HRV, neither at perimenopause nor at postmenopause. CONCLUSIONS: External sleep disturbance had only minor effects on HRV across menopause. MHT had no detectable HRV effects.
No takes yet. Share an insight, caveat, or question.
Virtanen et al. (2023) conducted an RCT in Climacteric (peri- and postmenopausal) (n=35). Menopausal hormone therapy (MHT) vs. Placebo was evaluated on Overnight heart rate variability (HRV). Menopausal hormone therapy had no detectable effects on overnight heart rate variability in peri- and postmenopausal women, while external sleep disturbance had only minor effects.
Synapse has enriched 10 related papers. Consider them for comparative context: